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The effect of cysteamine and epigallocatechin gallate on the inflammatory phenotype in 
cystic fibrosis  
Objectives: The self-degradative process, termed autophagy, is defective in cystic fibrosis 
(CF), as a result of abnormal function and production of the cystic fibrosis transmembrane 
conductance regulator (CFTR) protein. In CF the accumulation of defective CFTR in the 
cytosol and a lack of expression of functional CFTR on the cell membrane, leads to 
perturbation of autophagy, resulting in amplified inflammation. In this study, the anti-
inflammatory effect of pre-treating human bronchial epithelial cells (HBECs) and primary 
monocytes with the proteostasis regulator, cysteamine, and the flavonoid, epigallocatechin 
gallate (EGCG) was investigated.  
Methods: HBEC lines Beas-2b (WT), IB3-1 (CF - ȴ& ? ? ? ?t ? ? ? ?y ? ?h&/-1 (CF - ȴ& ? ? ? ?ȴ& ? ? ? ? ?
CUFI-4 (CF - ȴ& ? ? ? ?' ? ? ? ?ĂŶĚ&ƉĂƚŝĞŶƚƐ ? monocytes were studied. ELISAs were 
performed to measure IL-6, TNF and IL-10. Small molecule drugs, cysteamine (250PM) and 
EGCG (100PM), were used to treat both epithelial cell lines and patientƐ ? monocytes in vitro. 
LPS (10ng/ml) was used to stimulate both HBECs and monocytes. Western blots were used 
to demonstrate defective autophagy in the cell lines and in CF patient monocytes. 
Results: Autophagy proteins were shown to be deficient in CF monocytes compared to HCs, 
and cysteamine was successfully shown to recover the proteins. The epithelial cell lines and 
CF patients ? monocytes presented with a hyperinflammatory response to LPS, with raised 
levels of IL-6 and TNF. The levels of IL-6 and TNF were greatly reduced upon addition of 
cysteamine and EGCG. IL-10 levels were shown to be reduced in CF monocytes compared to 
HCs. Cysteamine and EGCG reduced the quantity of inflammatory cytokines secreted in 
HBECs and CF monocytes. 
Conclusion: These data show that CF has an exaggerated inflammatory response and a 
deficient anti-inflammatory response to LPS stimulation in comparison to HC, showing an 
inherent inflammatory state in CF. The results show that the combination of cysteamine and 
EGCG is considerably more potent a treatment than when they are used separately. 
Character Count: 1727 
Keywords: autophagy, inflammation, cystic fibrosis, cytokines 
 
Holbrook J1,2,3, Scambler T1, Lara-Reyna S1,2, Wong C1,2,3, Jarosz-Griffiths HH1,2,3, Savic S1,3,5, Peckham 
D ? ? ? ? ? ? and McDermott MF1 
1Leeds Institute of Rheumatic and Musculoskeletal Medicine, 2Leeds Institute of Biomedical and 
Clinical Sciences, 3Leeds Cystic Fibrosis Trust Strategic Research Centre,4Department of Biochemistry, 
University of Lausanne, Switzerland, 5ĞƉĂƌƚŵĞŶƚŽĨůŝŶŝĐĂů/ŵŵƵŶŽůŽŐǇĂŶĚůůĞƌŐǇ ?^ƚ:ĂŵĞƐ ?Ɛ
University Hospital, 6ĚƵůƚǇƐƚŝĐ&ŝďƌŽƐŝƐhŶŝƚ ?^ƚ:ĂŵĞƐ ?hŶŝǀĞƌƐŝƚǇ,ŽƐƉŝƚĂů 
